Serina Therapeutics, Inc.
SER
$1.77
-$0.13-6.84%
AMEX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -21.27M | -19.18M | -18.59M | -12.59M | -939.00K |
| Total Depreciation and Amortization | 74.00K | 73.00K | 105.00K | 145.00K | 186.00K |
| Total Amortization of Deferred Charges | 122.00K | 58.00K | 8.00K | 16.00K | 323.00K |
| Total Other Non-Cash Items | 1.35M | -374.00K | -423.00K | -5.29M | -16.06M |
| Change in Net Operating Assets | 1.52M | 1.47M | 2.39M | 2.10M | -3.40M |
| Cash from Operations | -18.20M | -17.96M | -16.51M | -15.62M | -19.88M |
| Capital Expenditure | -84.00K | -59.00K | -64.00K | -54.00K | -8.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -84.00K | -59.00K | -64.00K | -54.00K | -8.00K |
| Total Debt Issued | 4.91M | 4.91M | 5.02M | 118.00K | 643.00K |
| Total Debt Repaid | -- | -- | -1.00K | -9.00K | -155.00K |
| Issuance of Common Stock | 33.62M | 7.56M | 7.08M | 5.64M | 10.00M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 4.94M | 4.94M | 4.94M | 4.94M | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.92M | 0.00 | 4.92M | 4.92M | 4.92M |
| Cash from Financing | 38.55M | 17.41M | 21.96M | 15.60M | 15.40M |
| Foreign Exchange rate Adjustments | -8.00K | -14.00K | -2.00K | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 20.26M | -616.00K | 5.39M | -73.00K | -4.49M |